Events

Below is a list of events where CELT researchers and staff are presenting CELT research, or events that CELT is endorsing.

Securing the future: Shaping the UK strategy on long-acting therapeutics

10am-4pm (GMT), 6 November 2025, Liverpool UK

HALo is dedicated to advancing a national strategy that recognises the economic and healthcare potential of long-acting therapeutics in the UK. We aim to accelerate long-acting therapeutics by tackling key technical challenges, engaging patients, raising awareness across clinical and public groups, and establishing a national manufacturing strategy - from pre-clinical proof-of-concept to UK-wide GMP manufacturing - while creating a regulatory environment that supports rapid clinical evaluation and market access.

This event will bring together stakeholders from across the long-acting therapeutics landscape to explore current barriers and opportunities in manufacturing and adoption of LA medicines.

Confirmed speakers

An image showing the speakers for the HALo launch. They are: Professor Steve Rannard (HALo), Susan Cole (MHRA), Dr Inti Qurashi (M-RIC), Dr Christian Seiler (Viiv), Ian Lafferty (Upperton), Henry Dunne (MNS)

Agenda

Time	Lead	Title
9:30	Registration
10:00	Prof. Steve Rannard (HALo)	Welcome and opening remarks
10:05	Prof. Steve Rannard (HALo)	An introduction to HALo
10:20	Dr Inti Qurashi (NHS)	Long-acting therapeutics in mental health care
10:40	Susan Cole (MHRA)	From trials to market: Authorisation routes for long-acting therapeutics
11:00	Refreshment break
11:20	Dr Christian Seiler (ViiV)	Evolution of the ViiV pipeline into long-acting therapeutics
11:40	Ian Lafferty (Upperton)	Aseptic manufacture capacity to support early-stage development and manufacture of long-acting injectables
12:00	Henry Dunne (Microneedle Solutions)	Bridging the gaps - An SME view on long-acting microneedle development
12:20	All speakers	Panel discussion and open discussion
12:50	Lunch
13:50	HALo leadership team	Round table discussion
15:00	Refreshment break
15:20	Professor Trevor Farren (University of Nottingham)	Summary, reflection and open discussion
15:50	Professor Steve Rannard (HALo)	Closing remarks

Here is a link to a PDF copy of the agenda: agenda-securing-the-future-shaping-the-uk-strategy-on-long-acting-therapeutics

Register

Your insights would be invaluable to this conversation, and we would be delighted to have you, or a member of your team join us.

Contact the HALo team to register or find out further information.

AAPS 2025 PHarmSCi 360

9-12 November 2025, San Antonio USA

This four day conference is organised around six core areas; Discovery and basic research; Preclinical, clinical and translational sciences; Bioanalytics; Manufacturing and analytical characterization; Formulation and delivery; Professional advancement track.

CELT Co-Director, Professor Steve Rannard, will be presenting a talk titled 'Injectable nanosuspensions enabling long-acting delivery of small molecules and prodrugs'.

Five CELT members are also presenting posters at the conference:

Sam Galbraith - 'Polymer coated solid injectable dispersions for long-acting delivery of tenofovir alafenamide'
Dr James Hobson - 'Development of long-acting injectable formulations of next generation diarylquinolines for preventive therapy of tuberculosis infection'
Dr Cameron Hogarth - ‘Preclinical development of a long-acting injectable formulation of rifapentine from high throughput screening through to a GLP-toxicology study’
Dr Sam Morris - 'Control of particle size, distribution and modality of a rifapentine solid drug nanoparticle formulation through modified formulation approaches'
Dr Catherine Unsworth - ‘Preclinical development of long-acting injectable formulations of glecaprevir and pibrentasvir for curative treatment of Hepatitis C in low- and middle-income countries’

Find out more, including how to register, on the PHarmSCi 360 event page.

CELT's Community of Practice for long-acting therapeutics for maternal and paediatric health

14 January 2026, online webinar

Community of Practice context

Significant gaps currently exist in the development of new medicines for women of child-bearing age and children, compared with the general adult population. This gap could expand further with new treatment modalities like long-acting therapeutics. Additionally, the extent of breastfed infant exposure through breast milk is largely unknown.

The overarching aim of this Community of Practice (funded by global health agency Unitaid) is to catalyse the development and availability of long-acting therapeutics of value for maternal and paediatric health globally, including in low- and middle- income countries.

This will be achieved through the following specific objectives:

Engaging relevant stakeholders in academia, clinical practice, pharmaceutical industry, regulators, women and patient groups
Synthesise evidence-based perspectives on best practices for long-acting therapeutics
Disseminate outputs from the community of practice for uptake by the wider community.

The next Community of Practice webinar

The next online session will be held on Wednesday 14 January 2026, and is titled 'Opportunities and challenges for Long-acting postmenopausal osteoporosis drugs'. The guest speaker is Satinder Singh, Associate Director of DMPK at Aragen Life Sciences.

To join the Community of Practice and attend this meeting, please fill in this Expression of Interest form to receive an invite link.

We will use this Events page to keep you updated on the remaining events, so please check back. New members are welcome to join the Community of Practice at any point.

Previous events

26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025

The key takeaways from this workshop can be found on the event's enduring materials page and the abstracts are available in the British Journal of Clinical Pharmacology.

CELT's Community of Practice meetings

January meeting - Launch

A recording of the first session where the key objectives were set can be found on our YouTube channel.

March meeting - Dynamic paediatric and maternal physiology in long-acting therapeutics development

A recording of the first webinar addressing the dynamic physiology of both paediatric and maternal patients in long-acting therapeutics development is available on CELT's YouTube channel.

July meeting - First in person

We have separated the recordings that are available for each session. These were maternal health, paediatric health and global health.

Advances in Long-acting Therapeutics meeting

A recording of CELT's Dr Catherine Unsworth's 14 minute talk is available on CELT's YouTube channel.

LEAP | New Approaches to Bioequivalence Assessment and Generic Approvals for Long Acting/Extended Release Antiretroviral Formulations

Find all the recordings from the workshop talks on LEAP's Bioequivalence workshop recordings page.

LEAP | Long-acting Tuberculosis Drug Development Workshop 2024 - 15 April 2024

Watch a recording of CELT co-Director Prof. Andrew Owen's presentation.

Find all the recordings from the workshop on LEAP's long-acting tuberculosis recordings page.

19th Residential Course on Clinical Pharmacology and Antiretrovirals - 17-19 January 2024

Download the presentation decks on the Clinical Pharmacology and Antiretrovirals course page

LEAP | Investigator Meeting & Annual Workshop 2023 - 18 February 2023

Watch a recording of an update from LONGEVITY delivered by Professor Andrew Owen available on LEAP's investigator meeting and annual workshop 2023 page.

Access the full workshop on the event page.